P1428: IMPLICATIONS OF THE RUXOLITINIB (JAK1/JAK2 INHIBITOR) ON GRAFT-VERSUS-LEUKAEMIA EFFECT MEDIATED BY THE NK CELL. (23rd June 2022) - Durán, C.; Martín Cortázar, C.; Ferreras, C.; Navarro Zapata, A.; Clares Villa, L.; Al-akioui, K.; Escuredo, A.; Pernas, A.; Galán, V.; Bueno, D.; Sisinni, L.; Pérez Martínez, A.